SEC 13F Intelligence

Trails Edge Capital Partners, LP / RCUS

Trails Edge Capital Partners, LP’s Arcus Biosciences Inc Position

Does Trails Edge Capital Partners, LP own Arcus Biosciences Inc (RCUS)? Yes1.05M shares worth $23M (+5.19% of its 13F portfolio) as of Q1 2026, up from 916.3K shares the prior filed quarter.

Position Value
$23M
Q1 2026
Shares
1.05M
% of Portfolio
+5.19%
Quarters Held
2
currently held

Position History RCUS

Reported value by quarter
Q4 ’25: $22MQ4 ’25Q1 ’26: $23MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.05M$23M+5.19%
Q4 2025916.3K$22M+5.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of RCUS.